ALBERA, Carlo
ALBERA, Carlo
SCIENZE MEDICHE
6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID)
2012-01-01 Steven Nathan; Carlo Albera; Roland du Bois; Williamson Bradford; Ulrich Costabel; Talmadge King; Paul Noble; Steven Sahn; Dominique Valeyre
Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
2012-01-01 Ulrich Costabel; Carlo Albera; Williamson Bradford; Phil Hormel; Talmadge King; Paul Noble; Steven Sahn; Dominique Valeyre; Roland du Bois
Mode of Death in Patients with Pulmonary Arterial Hypertension
2013-01-01 Vizza CD; Pezzuto B; Badagliacca R; Poscia R; Mezzapesa M; Nocioni M; D'Alto M; Ghio S; Vitulo P; Mule M; Albera C; Fedele F.
Safety and tolerability of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) receiving commonly used concomitant medications
2012-01-01 Carlo Albera; Williamson Bradford; Ulrich Costabel; Talmadge King; Paul Noble; Steven Sahn; Dominique Valeyre; Roland du Bois
The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
2012-01-01 Dominique Valeyre; Carlo Albera; Williamson Bradford; Ulrich Costabel; Talmadge King; Paul Noble; Steven Sahn; Roland du Bois
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID) | 2012 | Steven Nathan; Carlo Albera; Roland du Bois; Williamson Bradford; Ulrich Costabel; Talmadge King; Paul Noble; Steven Sahn; Dominique Valeyre | |
| Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) | 2012 | Ulrich Costabel; Carlo Albera; Williamson Bradford; Phil Hormel; Talmadge King; Paul Noble; Steven Sahn; Dominique Valeyre; Roland du Bois | |
| Mode of Death in Patients with Pulmonary Arterial Hypertension | 2013 | Vizza CD; Pezzuto B; Badagliacca R; Poscia R; Mezzapesa M; Nocioni M; D'Alto M; Ghio S; Vitulo P; Mule M; Albera C; Fedele F. | |
| Safety and tolerability of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) receiving commonly used concomitant medications | 2012 | Carlo Albera; Williamson Bradford; Ulrich Costabel; Talmadge King; Paul Noble; Steven Sahn; Dominique Valeyre; Roland du Bois | |
| The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) | 2012 | Dominique Valeyre; Carlo Albera; Williamson Bradford; Ulrich Costabel; Talmadge King; Paul Noble; Steven Sahn; Roland du Bois |